2010 Annual Report & 2009 Statistical Review

Transcription

1 00 Annual Report & 009 Statistical Review Bruno Cancer Center Cancer Program WHERE HOPE AND MEDICINE MEET

2

3 00 Annual Report & 009 Statistical Review Call To Action Healthcare That Works Healthcare That is Safe Healthcare That Leaves No One Behind For Life Core Values We are called to: Service of the Poor Reverence Integrity Wisdom Creativity Dedication Enabling Strengths Inspired People Trusted Partnerships Empowering Knowledge Vital Presence Stewardship

4 Cancer Committee - 00 Chairman s Annual Report Sheldon Black, M.D. As Chairman of the Cancer Committee, I am pleased to present the 00 Annual Report summarizing the 009 Cancer Program at St. Vincent s Birmingham. St. Vincent s Bruno Cancer Center diagnosed and managed over,900 total cancers in 009 with primary sites consisting of prostate, breast, lung, colorectal, and oral cavity. Radiation Oncology had an active year in 009. More than 9,700 radiation therapy treatments and/or procedures were performed representing an increase of 5% over 008. In particular, Brachytherapy demonstrated the most growth. The Medical Oncology Center program remained robust in clinic activities and clinical research. There were more than 4,000 patient visits and over 7,000 treatments (primarily chemotherapy) administered in the Bruno Cancer Center. Also, our Talladega clinic saw,00 patients and administered over 500 treatments. Medical oncology clinical trials involved a variety of cancer types and therapies including new agents in late phase trials for FDA approval. Research protocols included Neratinib and Avastin plus chemotherapy as adjuvant therapies for breast cancer. The center served as the primary national site for investigation of Urazil ointment for treatment of Xeloda induced skin syndrome: seven of our breast cancer patients were accessioned to this innovative trial. Other protocols of interest were Treanda and Ofatumumab for treatment of previously untreated indolent B cell non-hodgkin s lymphoma, and Gemcitabine/Carboplatin with and without BSI-0 in treatment of squamous cell lung cancer. Protocols available during the year included treatments for multiple myeloma, metastatic breast cancer, high risk myelodysplasia, and advanced pancreatic cancer. The medical oncology service continues its long standing policy of aggressively pursuing state-of-the-art therapies and investigational therapies for our patients at top tier cancer centers, including MD Anderson, Vanderbilt University, and Mayo Clinic. We have established collaborative efforts with these institutions and others, along with our in house clinical research program, in order to provide Bruno Cancer Center patients with state-of-the-art treatment options. St. Vincent s Cancer Committee continues to incorporate a multidisciplinary team of oncologists, surgeons, pathologists, radiologists, dietitians, social workers, and others to ensure best practice and improve the care of cancer patients. Identifying patient needs and developing strategies to meet those needs will be our continued focus for the upcoming year. St. Vincent s Bruno Cancer Center anticipates renovating and expanding over the next year to create a more healing, comforting environment of care. The expansion will also allow us to provide more opportunities for patients and their families, as well as offer a variety of treatment options and survivorship support. Sheldon Black, MD Cancer Committee Chairman Matthew Abele, MD Dermatology J. Max Austin, MD Gynecologic Oncology Mack Barnes, MD Gynecologic Oncology John Blalock, Jr., MD General Surgery Cara Bondly, MD Hematology/Oncology Tom Brown, MD Internal Medicine Gray Buck, III, MD General Surgery Charles Bugg, Jr., MD Urology Philip Fischer II, MD General Surgery Jon David Holmes, MD Oral/Maxillofacial Surgery Caroline McCall, MD Pathology Jason Moellinger, MD Urology Robert Pritchett, MD Dermatology Sally Salter, MD General Surgery Susan Salter, MD Radiation Oncologist James Strickland, Jr., MD Pulmonary Disease Shane Wear, MD Radiology Kris Boone Cancer Center Manager Diane Cherry, RN Patient Care Supervisor, Oncology Unit Jeff Daniel Administrative Director of Clinical Services Cathleen Dixon, MSW Social Services Alison Enochs American Cancer Society Diane Lolley, RHIT Cancer Registry Edward Butch Pair Clinical Excellence Rosalind Patterson, RHIT, CTR Cancer Registry Kimberly Rider Wellness Services Janice Simmons, RN Oncology Unit Manager

5 Cancer Support Services St. Vincent s Bruno Cancer Center provides comprehensive support services to help patients focus their energy on combating their disease. Designed to improve long-term outcomes and survivorship, these services address a complex range of medical, social, and emotional needs. Resources are available to patients and their families and include ongoing cancer support groups, access to social workers, and counseling in nutrition, diet, and lifestyle changes. General Cancer Support Group Cancer patients, survivors and their families are invited to attend a cancer support group meeting, which meets the first Tuesday of every month in the Bruno Conference Center. The group is led by Louis Josof. For more information, call Katherine at Breast Cancer Support Group This group provides education and support for those living with breast cancer and the significant people in their lives. The group meets the second Tuesday of every month in the Bruno Conference Center. Participants are encouraged to attend at any point in the diagnosis and treatment journey. For more information, please call Katherine at Look Good Feel Better Look Good Feel Better is a free program designed to help female cancer patients with new beauty techniques for appearance-related side effects of chemotherapy and radiation treatments. Women meet in a group setting to learn techniques to help restore their appearance and self-esteem through the use of makeup, wigs, scarves and other accessories. The group meets the first Monday of each month at St. Vincent s Bruno Cancer Center. For more information or to register for a session, call Camp Bluebird Camp Bluebird offers recreation, relaxation, crafts, activities, and the opportunity to openly discuss the experiences and emotions associated with cancer with other survivors. Camp Bluebird is open to adults, ages 8 or older, who have been diagnosed or treated for cancer at St. Vincent s Birmingham. The camp is generally held in the fall at Camp Sumatanga. For more information, contact Katherine at Bruno Cancer Center Offered Free Screenings Since early detection is one of the best defenses against cancer, the Bruno Cancer Center organized three successful cancer screenings for the community in 009. A Skin Cancer screening was held in June with 7 participants with 9 biopsies recommended. A Head and Neck Cancer Screening was held in August with participants. Of those, three had normal findings and nine with abnormal findings leading to further head and neck evaluation. A prostate cancer screening was held in September with 64 participants. Of those 64, four had a normal prostate exam and normal PSA, 54 had increased PSA with a normal exam, one had an increased PSA with an enlarged prostate, three had a normal PSA with an enlarged prostate, and two had an increased PSA and an abnormal highly suspicious exam.

6 Charts and Graphs American Cancer ACS Top Society Site (ACS) Comparison Top Site Comparison 35 8 St. Vincent's Vincent s Birmingham ACS Estimated Alabama ASC ACS Estimated National Percentage Lung Breast Prostate Colon & Rectum Urinary Bladder Melanoma Non-Hodgkin Lymphoma Males St. Vincent s Birmingham Top Ten Cancer Sites by Sex Females. Prostate. Breast. Lung & Bronchus. Colon & Rectum 3. Colon & Rectum 3. Lung & Bronchus 4. Urinary Bladder 4. Corpus Uteri 5. Non-Hodgkin Lymphoma 5. Gum & Other Mouth 6. Tongue 6. Benign Brain & Other Nervous System 7. Kidney & Renal Pelvis 7. Brain 8. Gum & Other Mouth 8. Ovary 9. Leukemia 9. Melanoma-Skin 0. Benign Brain & Other Nervous System 0. Thyroid

7 Outcome Analysis on Prostate Cancer Charles E. Bugg, Jr., M.D. Scott Tully, M.D. According to the National Cancer Institute s Surveillance, Epidemiology and End Results (SEER) Program, it is estimated that 7,730 men will be diagnosed with prostate cancer and 3,050 men will die of cancer of the prostate in 00. Prostate cancer is the second most common type of cancer among men in the United States and only skin cancer is more common. The number of prostate cancer cases has steadily increased over the past five years at St. Vincent s Birmingham. In 009 alone, 583 new cases of prostate cancer were diagnosed at St. Vincent s Birmingham. Of those patients, 54 elected surgery and most men were within the age range (see Figure ). Figure A review of survival data of St. Vincent s Birmingham compared to the National Cancer Database (NCDB) shows very favorable outcomes (Figure ). Five-year survival rates for stage I, II, and III matches or exceeds the NCDB benchmarks when compared to 544 other Comprehensive Community Cancer Centers. These benchmarks are one example of St. Vincent s ongoing commitment to improve the quality of cancer care and to better contribute to the patient management process. continued...

8 continued... Outcome Analysis on Prostate Cancer Observed Survival For Prostate C69 Cases Diagnosed in 003 Data from Program (St. Vincent s Hospital Birmingham) The information within this graphic is not to be used for clinical decision making. Figure Observed Survival For Prostate C69 Cases Diagnosed in 003 Data from 544 Programs (Comprehensive Community Cancer Center) The information within this graphic is not to be used for clinical decision making. Figure 3

9 continued... Outcome Analysis on Prostate Cancer In 009, Dr. Bugg and Dr. Tully surveyed,43 prostate cancer patients to take a closer look at recurrence rate. Of those patients surveyed, 75% of patients were stage T with a Prostate Specific Antigen (PSA) recurrence of 6%; 0% were stage T3 with a PSA recurrence of 4%; 5% were stage T4 with a recurrence rate of 5%. St. Vincent s multidisciplinary team of urologists, radiation and medical oncologists, and other physicians collaborate at our weekly tumor conference to ensure best practice of prostate patients. Information from the PSA test, rectal exam, and Gleason Scores enables this group to discuss patient s risk and individualize a treatment plan using National Comprehensive Cancer Network (NCCN) guidelines. Robotic Prostatectomy St. Vincent s Birmingham was one of the first hospitals in the Southeast to have the da Vinci Surgical System robot. More than 4,00 urology procedures have been performed using the da Vinci Surgical Robotic System since 00. Surgeons use a three-dimensional computer vision system to manipulate robotic arms. These robotic arms hold special surgical instruments that are inserted into the abdomen through small incisions. A laparoscope, which is a lighted telescope, is inserted through one incision and then connected to the computer monitor that will allow the surgeon to look inside the body. The three-dimensional view helps the surgeon easily find the nerves and muscles around the prostate. The robotic arms can rotate a full 360 degrees, allowing the surgeon to manipulate surgical instruments with flexibility. The surgeon can perform the same nerve-sparing procedure as done in a conventional open prostatectomy. The prostate, lymph nodes, seminal vesicles and surrounding tissue are removed through the small incisions, which are later closed with small stitches. According to Dr. Charles E. Bugg, Jr. and Dr. Scott Tully, the robotic procedure allows for a rapid recovery period and most patients can go home within 4 hours and return to normal activities within one to two weeks following surgery. Patients have reported that they have very little pain and are able to walk the evening of surgery. As with any surgical procedure, none of these benefits can be guaranteed as surgery is both patient and procedure dependent. Alabama s Leader in Robotic Surgery More Robots More Experience stvhs.com/robotics

10 Cancer Summary by County Birmingham The top five counties served in 009 were Jefferson, Shelby, Walker, St. Clair, and Talladega. Of the,849 cases treated, 39 were referred to St. Vincent s Birmingham from outside the state of Alabama.

11 PRIMARY SITE TABULATION FOR 009 ANALYTIC CASES sex STAGE PRIMARY SITE TOTAL M F 0 I II III IV UNK N/A Lip Tongue Salivary Glands Floor of Mouth Gum & Other Mouth Tonsil Oropharynx Hypopharynx Other Oral Cavity & Pharynx ORAL CAVITY & PHARYNX Esophagus Stomach Small Intestine Colon Excluding Rectum Rectum and Rectosigmoid Anus, Anal Canal & Anorectum Liver & Intrahepatic Bile Ducts Gallbladder Other Biliary Pancreas Peritoneum, Omentum & Mesentery DIGESTIVE Nose,Nasal Cavity & Middle Ear Larynx Lung & Bronchus Trachea, Mediastinum RESPIRATORY SYSTEM BONES & JOINTS SOFT TISSUE Melanoma Skin Other Non-Epithelial Skin SKIN EXCLUDING BASAL & SQUAMOUS BREAST Cervix Uteri Corpus & Uterus, NOS Ovary Vagina Vulva Other Female Genital Organs FEMALE GENITAL SYSTEM Prostate Testis MALE GENITAL SYSTEM Urinary Bladder Kidney & Renal Pelvis Ureter URINARY SYSTEM Brain Cranial Nerves Other Nervous System BRAIN & OTHER NERVOUS SYSTEM Thyroid Other Endocrine including Thymus ENDOCRINE SYSTEM Hodgkin Lymphoma Non-Hodgkin Lymphoma LYMPHOMA MYELOMA Lymphocytic Leukemia Myeloid & Monocytic Leukemia Other Leukemia LEUKEMIA MESOTHELIOMA NON-LEUKEMIA 99503, 99603, 9963, 9963, 99803, 9983, UNKNOWN PRIMARY Total Analytic,849, Total Cases,96,

12 Bruno Cancer Center Cancer Program Bruno Cancer Center 80 St. Vincent s Drive Birmingham, Alabama